Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2017

01-01-2017 | Original Article

Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity

Authors: Edward P. Weiss, Dominic N. Reeds, Uthayashanker R. Ezekiel, Stewart G. Albert, Dennis T. Villareal

Published in: Endocrine | Issue 1/2017

Login to get access

Abstract

Dietary calorie restriction and exercise promote weight loss and may have additive effects for improving insulin sensitivity, independent of weight loss. It is not known if these effects are attributable to changes in circulating cytokines. We evaluated the hypothesis that modest, matched weight loss induced by calorie restriction and exercise have additive effects on circulating cytokines and these changes correlate with improvements in insulin sensitivity. Overweight and sedentary women and men (n = 52, 45–65 years) were randomized to undergo 7 % weight loss by using 3–6 months of calorie restriction, exercise, or a combination of both calorie restriction and exercise. Concentrations of cytokines and hormones were measured in fasting and oral glucose tolerance test blood samples. Insulin sensitivity was estimated based on oral glucose tolerance test for glucose and insulin. With all groups combined, fasting leptin (p < 0.0001) and high molecular weight adiponectin (p = 0.04) decreased and pentraxin-3 increased (p < 0.0001), in a manner that correlated with improvements in insulin sensitivity (all p ≤ 0.0002). These changes, combined with decreases in glucose-dependent insulinotropic polypeptide from the oral glucose tolerance test, explained 63 % of the variance (p < 0.0001) in insulin sensitivity improvements. Exercise and calorie restriction had additive effects on leptin, with a similar trend for high molecular weight adiponectin. Monocyte chemoattractant protein-1 and C-reactive protein concentrations did not change. Calorie restriction and exercise had opposite effects on soluble tumor necrosis factor receptor-1. Modest weight loss in overweight adults decreases serum leptin and high molecular weight adiponectin, and increases pentraxin-3 concentrations in a manner that correlates with increased insulin sensitivity. Exercise has additive effects to those induced by calorie restriction for reductions in leptin and possibly adiponectin. These changes may contribute to the additive effects of calorie restriction and exercise for improving insulin sensitivity.
Literature
1.
W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002)CrossRefPubMed
2.
3.
E.P. Weiss, S.B. Racette, D.T. Villareal, L. Fontana, K. Steger-May, K.B. Schechtman, S. Klein, J.O. Holloszy; Washington University School of Medicine, C.G., Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am. J. Clin. Nutr. 84(5), 1033–1042 (2006)PubMedPubMedCentral
4.
5.
E.P. Weiss, S.G. Albert, D.N. Reeds, K.S. Kress, U.R. Ezekiel, J.L. McDaniel, B.W. Patterson, S. Klein, D.T. Villareal, Calorie restriction and matched weight loss from exercise: independent and additive effects on glucoregulation and the incretin system in overweight women and men. Diabetes Care 38(7), 1253–1262 (2015). doi:10.​2337/​dc14-2913 CrossRefPubMedPubMedCentral
6.
Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat , Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). (The National Academies Press, Washington DC), (2005)
7.
J.F. Sallis, Seven-day physical activity recall. Med. Sci. Sports Exerc. 29(6 Supplement), S89–S103 (1997)
8.
M.L. Delporte, S.A. El Mkadem, M. Quisquater, S.M. Brichard, Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 287(3), E446–E453 (2004). doi:10.​1152/​ajpendo.​00488.​2003 CrossRefPubMed
9.
C.R. Bruce, V.A. Mertz, G.J. Heigenhauser, D.J. Dyck, The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54(11), 3154–3160 (2005)CrossRefPubMed
10.
11.
H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, M. Kasuga, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116(6), 1494–1505 (2006). doi:10.​1172/​jci26498 CrossRefPubMedPubMedCentral
12.
A. Witasp, J.J. Carrero, K. Michaelsson, H. Ahlstrom, J. Kullberg, V. Adamsson, U. Riserus, A. Larsson, J. Helmersson-Karlqvist, L. Lind, P. Stenvinkel, J. Arnlov, Inflammatory biomarker pentraxin-3 (PTX3) in relation to obesity, body fat depots and weight loss. Obesity (Silver Spring) 22(5), 1373–1379 (2014). doi:10.​1002/​oby.​20695 CrossRef
13.
A. Miyaki, S. Maeda, Y. Choi, N. Akazawa, Y. Tanabe, R. Ajisaka, Habitual aerobic exercise increases plasma pentraxin-3 levels in middle-aged and elderly women. Appl. Physiol. Nutr. Metab. 37(5), 907–911 (2012). doi:10.​1139/​h2012-069 CrossRefPubMed
14.
World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Document #WHO/NCD/NCS/99.2. (WHO Press, Geneva Switzerland), (1999)
15.
American Diabetes Association, 2. Classification and diagnosis of diabetes. Diabetes Care 39(Suppl 1), S13–S22 (2016). doi:10.​2337/​dc16-S005
16.
D.B. Allison, F. Paultre, C. Maggio, N. Mezzitis, F.X. Pi-Sunyer, The use of areas under curves in diabetes research. Diabetes Care 18(2), 245–250 (1995)CrossRefPubMed
17.
M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9), 1462–1470 (1999)CrossRefPubMed
18.
M. Stumvoll, A. Mitrakou, W. Pimenta, T. Jenssen, H. Yki-Jarvinen, T. Van Haeften, W. Renn, J. Gerich, Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23(3), 295–301 (2000)CrossRefPubMed
19.
J.J. Hernandez-Morante, F.I. Milagro, J.A. Lujan, J.A. Martinez, S. Zamora, M. Garaulet, Insulin effect on adipose tissue (AT) adiponectin expression is regulated by the insulin resistance status of the patients. Clin. Endocrinol. (Oxf.) 69(3), 412–417 (2008). doi:10.​1111/​j.​1365-2265.​2008.​03185.​x CrossRef
20.
21.
S. Mai, G.E. Walker, A. Brunani, G. Guzzaloni, G. Grossi, A. Oldani, G. Aimaretti, M. Scacchi, P. Marzullo, Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity. Sci. Rep. 4, 5803 (2014). doi:10.​1038/​srep05803 CrossRefPubMedPubMedCentral
22.
W.S. Yang, W.J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, C.L. Chao, C.L. Chen, T.Y. Tai, L.M. Chuang, Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 86(8), 3815–3819 (2001). doi:10.​1210/​jcem.​86.​8.​7741 CrossRefPubMed
23.
A.S. Ryan, B.J. Nicklas, D.M. Berman, D. Elahi, Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int. J. Obes. Relat. Metab. Disord. 27(9), 1066–1071 (2003)CrossRefPubMed
24.
F. Abbasi, S.A. Chang, J.W. Chu, T.P. Ciaraldi, C. Lamendola, T. McLaughlin, G.M. Reaven, P.D. Reaven, Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290(1), R139–R144 (2006)CrossRefPubMed
25.
F. Abbasi, C. Lamendola, T. McLaughlin, J. Hayden, G.M. Reaven, P.D. Reaven, Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism 53(3), 280–283 (2004)CrossRefPubMed
26.
27.
P. Singh, P. Sharma, K.R. Sahakyan, D.E. Davison, F.H. Sert-Kuniyoshi, A. Romero-Corral, J.M. Swain, M.D. Jensen, F. Lopez-Jimenez, T. Kara, V.K. Somers, Differential effects of leptin on adiponectin expression with weight gain versusPlease provide volume number and page range in the reference Singh et al. (2015). obesity. Int. J. Obes. (Lond.) (2015). doi:10.​1038/​ijo.​2015.​181
28.
J. Hector, B. Schwarzloh, J. Goehring, T.G. Strate, U.F. Hess, G. Deuretzbacher, N. Hansen-Algenstaedt, F.U. Beil, P. Algenstaedt, TNF-alpha alters visfatin and adiponectin levels in human fat. Horm. Metab. Res. 39(4), 250–255 (2007). doi:10.​1055/​s-2007-973075 CrossRefPubMed
29.
L. Ortega Moreno, M. Copetti, A. Fontana, C. De Bonis, L. Salvemini, V. Trischitta, C. Menzaghi, Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes. Cardiovasc. Diabetol. 15(1), 17 (2016). doi:10.​1186/​s12933-016-0339-z CrossRefPubMedPubMedCentral
30.
G. Witberg, C.R. Ayers, A.T. Turer, E. Lev, R. Kornowski, J. de Lemos, I.J. Neeland, Relation of adiponectin to all-cause mortality, cardiovascular mortality, and major adverse cardiovascular events (from the Dallas Heart Study). Am. J. Cardiol. 117(4), 574–579 (2016). doi:10.​1016/​j.​amjcard.​2015.​11.​067 CrossRefPubMed
31.
S.H. Choi, E.J. Ku, E.S. Hong, S. Lim, K.W. Kim, J.H. Moon, K.M. Kim, Y.J. Park, K.S. Park, H.C. Jang, High serum adiponectin concentration and low body mass index are significantly associated with increased all-cause and cardiovascular mortality in an elderly cohort, “adiponectin paradox”: the Korean Longitudinal Study on Health and Aging (KLoSHA). Int. J. Cardiol. 183, 91–97 (2015). doi:10.​1016/​j.​ijcard.​2015.​01.​057 CrossRefPubMed
32.
E. Sook Lee, S.S. Park, E. Kim, Y. Sook Yoon, H.Y. Ahn, C.Y. Park, Y. Ho Yun, S. Woo Oh, : Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. Int. J. Epidemiol. 42(4), 1029–1039 (2013). doi:10.​1093/​ije/​dyt087 CrossRefPubMed
33.
L. Deban, R.C. Russo, M. Sironi, F. Moalli, M. Scanziani, V. Zambelli, I. Cuccovillo, A. Bastone, M. Gobbi, S. Valentino, A. Doni, C. Garlanda, S. Danese, G. Salvatori, M. Sassano, V. Evangelista, B. Rossi, E. Zenaro, G. Constantin, C. Laudanna, B. Bottazzi, A. Mantovani, Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat. Immunol. 11(4), 328–334 (2010). doi:10.​1038/​ni.​1854 CrossRefPubMed
34.
N. Abu Seman, A. Witasp, W.N. Wan Mohamud, B. Anderstam, K. Brismar, P. Stenvinkel, H.F. Gu, Evaluation of the association of plasma pentraxin-3 levels with type 2 diabetes and diabetic nephropathy in a Malay population. J. Diabetes Res. 2013, 298019 (2013). doi:10.​1155/​2013/​298019 CrossRefPubMedPubMedCentral
35.
S.H. Chu, J.H. Park, M.K. Lee, Y. Jekal, K.Y. Ahn, J.Y. Chung, D.H. Lee, E.S. Kim, M. Naruse, J.A. Im, I.D. Kong, C.H. Chung, J.W. Lee, K.M. Chung, Y.B. Kim, J.Y. Jeon, The association between pentraxin-3 and insulin resistance in obese children at baseline and after physical activity intervention. Clin. Chim. Acta 413(19-20), 1430–1437 (2012). doi:10.​1016/​j.​cca.​2012.​06.​002 CrossRefPubMed
36.
R. Barazzoni, S. Palmisano, G. Gortan Cappellari, M. Giuricin, E. Moretti, P. Vinci, A. Semolic, G. Guarnieri, M. Zanetti, N. Manzini, Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers. Surg. Obes. Relat. Dis. 12(1), 23–32 (2016). doi:10.​1016/​j.​soard.​2015.​04.​013 CrossRefPubMed
37.
L. Fontana, D.T. Villareal, E.P. Weiss, S.B. Racette, K. Steger-May, S. Klein, J.O. Holloszy, Washington University School of Medicine, C.G.: calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial. Am. J. Physiol. Endocrinol. Metab. 293(1), E197–E202 (2007). doi:10.​1152/​ajpendo.​00102.​2007 CrossRefPubMed
38.
R. Yu, C.S. Kim, B.S. Kwon, T. Kawada, Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity (Silver Spring) 14(8), 1353–1362 (2006). doi:10.​1038/​oby.​2006.​153 CrossRef
39.
E.P. Weiss, S.B. Racette, D.T. Villareal, L. Fontana, K. Steger-May, K.B. Schechtman, S. Klein, J.O. Holloszy, Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am. J. Clin. Nutr. 84(5), 1033–1042 (2006)PubMedPubMedCentral
40.
N. Petrovsky, L.C. Harrison, The chronobiology of human cytokine production. Int. Rev. Immunol. 16(5-6), 635–649 (1998)CrossRefPubMed
41.
D.E. Kelley, R. Wing, C. Buonocore, J. Sturis, K. Polonsky, M. Fitzsimmons, Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 77(5), 1287–1293 (1993). doi:10.​1210/​jcem.​77.​5.​8077323.​ PubMed
42.
L.J. Joseph, T.A. Trappe, P.A. Farrell, W.W. Campbell, K.E. Yarasheski, C.P. Lambert, W.J. Evans, Short-term moderate weight loss and resistance training do not affect insulin-stimulated glucose disposal in postmenopausal women. Diabetes Care 24(11), 1863–1869 (2001)CrossRefPubMed
43.
L.J. Joseph, R.L. Prigeon, J.B. Blumenthal, A.S. Ryan, A.P. Goldberg, Weight loss and low-intensity exercise for the treatment of metabolic syndrome in obese postmenopausal women. J. Gerontol. A. Biol. Sci. Med. Sci. 66(9), 1022–1029 (2011). doi:10.​1093/​gerona/​glr093 CrossRefPubMed
44.
E. Kirk, D.N. Reeds, B.N. Finck, S.M. Mayurranjan, B.W. Patterson, S. Klein, Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 136(5), 1552–1560 (2009)CrossRefPubMedPubMedCentral
45.
I.M. Jazet, G. Schaart, A. Gastaldelli, E. Ferrannini, M.K. Hesselink, P. Schrauwen, J.A. Romijn, J.A. Maassen, H. Pijl, D.M. Ouwens, A.E. Meinders, Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia 51(2), 309–319 (2008). doi:10.​1007/​s00125-007-0862-2 CrossRefPubMed
Metadata
Title
Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity
Authors
Edward P. Weiss
Dominic N. Reeds
Uthayashanker R. Ezekiel
Stewart G. Albert
Dennis T. Villareal
Publication date
01-01-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1093-4

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue

Endocrine Imaging

External ear invasion from an anaplastic thyroid cancer

Endocrine Imaging

Persistent hyperparathyroidism due to ectopic parathyroid gland

Original Article

Hypoxia and extra-cellular matrix gene expression in adipose tissue associates with reduced insulin sensitivity in black South African women

Original Article

Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia

Clinical Management of Endocrine Diseases

SIADH: differential diagnosis and clinical management

Original Article

Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits